Main content

    Pediatric Gastroenterology / Interventional
    Endoscopy Clinical Trials

    Gastroenterology Services

    Interventional Endoscopy Services

    Pediatric Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov


    Title: A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
    Decscription: Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
    Investigator: Antonio Quiros, MD
    Eligibility: Subjects less than 17 years of age with confirmed IBD
    Status: Active and open to enrollment
    Contact: Chanel Durley, 415-600-3246, Email: DurleyC@cpmcri.org about Study IBD Registry

    Title: Genome-Wide Association (GWA) Identified Predictors of Response to Anti-TNFa Therapy in Pediatric Inflammatory Bowel Disease
    Decscription: To examine the association between genetic loci identified by Genome Wide Association Studies (GWAS) and therapeutic responsiveness to anti-TNFa therapy
    Investigator: Antonio Quiros, MD
    Eligibility: Subjects up to 17 years of age with confirmed IBD who will be receiving infliximab as part of their standard of care
    Status: Active and open to enrollment
    Contact: Chanel Durley, 415-600-3246, Email: DurleyC@cpmcri.org about Study GWA

    Title: The Epidemiology of Pediatric Inflammatory Bowel Disease in the Western Region of North America
    Decscription: A prospective clinical registry in the western region of North America for all children with IBD
    Investigator: Antonio Quiros, MD
    Eligibility: Subjects up to 17 years of age with confirmed IBD
    Status: Active and open to enrollment
    Contact: Chanel Durley, 415-600-3246, Email: DurleyC@cpmcri.org about Study Western IBD registry

    • updated March 2012

    Back to top